SCHEMBL22768248

SCHEMBL22768248

Cc1cc(Nc2cc3cn[nH]c3cc2Br)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 3/20 0.41
▸ MKNK1 Q9BUB5 2/20 0.41
▸ TGFBR1 P36897 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GRM4 Q14833 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ CDC7 O00311 2/20 0.40
▸ AXL P30530 1/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ TDO2 P48775 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ EIF2AK2 P19525 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22655752 0.88 MAOB (0.49) P2RX7MKNK1CDC7AXLMAOB
SCHEMBL30177058 0.88 MAOB (0.49) P2RX7MKNK1CDC7AXLMAOB
SCHEMBL22768570 0.84 AXL (0.51) MKNK1GRM4AXLIDO1TDO2
SCHEMBL21856670 0.83 CDC7 (0.53) MKNK1ALDH1A1CDC7AXL
SCHEMBL30176980 0.83 CDC7 (0.53) MKNK1ALDH1A1CDC7AXL
SCHEMBL30936711 0.79 TGFBR1 (0.38) P2RX7TGFBR1GRM4ALDH1A1MAPT
SCHEMBL27216850 0.79 TGFBR1 (0.38) P2RX7TGFBR1GRM4ALDH1A1MAPT
SCHEMBL29535923 0.78 GRM4 (0.39) P2RX7TGFBR1L3MBTL1GRM4ALDH1A1
SCHEMBL21901151 0.78 GRM4 (0.39) P2RX7TGFBR1L3MBTL1GRM4ALDH1A1
SCHEMBL21856798 0.78 CDC7 (0.53) MKNK1ALDH1A1CDC7AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247160-A1 CONDENSED TRYCICLIC PYRROLES AS ALPHA-1 ANTITRYPSIN MODULATORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2020-12-10 — — WO disclosed
Send feedback